应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BK4139 生物科技
未开盘 09-01 16:00:00 EDT
1,361.69
+17.07
+1.27%
最高
1,361.91
最低
1,344.61
成交量
6.46亿
今开
1,344.61
昨收
1,344.62
日振幅
1.29%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
175.50亿
换手率
--
流通股本
0.00
市净率
8.126907
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
BioRestorative Therapies公司宣布任命Anna Skowron为首席财务官，自2026年8月27日起生效
美股速递 · 18:06
BioRestorative Therapies公司宣布任命Anna Skowron为首席财务官，自2026年8月27日起生效
美股中概股盘前多数下跌，蔚来跌3%
智通财经 · 16:01
美股中概股盘前多数下跌，蔚来跌3%
再鼎医药早盘涨逾6% DLL3 ADC启动一线SCLC全球三期临床
新浪港股 · 10:16
再鼎医药早盘涨逾6% DLL3 ADC启动一线SCLC全球三期临床
昨夜今晨｜美伊冲突升级，三大指数下跌；苹果换帅首日涨近3%，戴尔绩后大涨，谷歌本周拟发Gemini 3.8 Flash
老虎资讯综合 · 07:03
昨夜今晨｜美伊冲突升级，三大指数下跌；苹果换帅首日涨近3%，戴尔绩后大涨，谷歌本周拟发Gemini 3.8 Flash
美国财长贝森特谈及债券收益率：最重要的是实现更高水平的经济增长。
智通财经 · 06:14
美国财长贝森特谈及债券收益率：最重要的是实现更高水平的经济增长。
Hyperliquid Strategies于2026年9月1日签署主厨购买协议第一修正案——SEC文件披露
美股速递 · 05:02
Hyperliquid Strategies于2026年9月1日签署主厨购买协议第一修正案——SEC文件披露
aTyr Pharma更新计划中Efzofitimod治疗肺结节病III期研究的监管反馈时间表
美股速递 · 04:37
aTyr Pharma更新计划中Efzofitimod治疗肺结节病III期研究的监管反馈时间表
Emergent BioSolutions获增购Cyfendus（Av7909）合同修订——SEC文件披露
美股速递 · 04:15
Emergent BioSolutions获增购Cyfendus（Av7909）合同修订——SEC文件披露
Ultragenyx宣布Genglycos™（亦称DTX401）AAV基因疗法治疗GSD Ia的96周随机安慰剂对照交叉试验成功发表于《遗传代谢病杂志》
美股速递 · 04:07
Ultragenyx宣布Genglycos™（亦称DTX401）AAV基因疗法治疗GSD Ia的96周随机安慰剂对照交叉试验成功发表于《遗传代谢病杂志》
阿尔法计算公司获纳斯达克额外180天宽限期，以满足最低股价要求
美股速递 · 01:07
阿尔法计算公司获纳斯达克额外180天宽限期，以满足最低股价要求
FibroBiologics宣布获得美国新专利：利用成纤维细胞条件培养基治疗椎间盘退行性疾病
美股速递 · 09-01 20:31
FibroBiologics宣布获得美国新专利：利用成纤维细胞条件培养基治疗椎间盘退行性疾病
Valion Bio Inc宣布高层任命：Lisa Wolf出任总裁兼首席运营官，并继续兼任首席财务官
美股速递 · 09-01 20:12
Valion Bio Inc宣布高层任命：Lisa Wolf出任总裁兼首席运营官，并继续兼任首席财务官
KALA BIO携手Virotek，拟签署美国独家经销协议，共同推进眼科基因检测项目
美股速递 · 09-01 19:45
KALA BIO携手Virotek，拟签署美国独家经销协议，共同推进眼科基因检测项目
Kazia Therapeutics公布临床前数据：Paxalisib可重编程免疫治疗耐药的MSS/pMMR结直肠癌并增强免疫治疗应答
美股速递 · 09-01 19:31
Kazia Therapeutics公布临床前数据：Paxalisib可重编程免疫治疗耐药的MSS/pMMR结直肠癌并增强免疫治疗应答
Kazia Therapeutics二期试验预计2027年第一季度启动入组，年底前完成全部招募
美股速递 · 09-01 19:31
Kazia Therapeutics二期试验预计2027年第一季度启动入组，年底前完成全部招募
Kazia Therapeutics计划开展Paxalisib单药及联合帕博利珠单抗的五臂II期临床试验
美股速递 · 09-01 19:31
Kazia Therapeutics计划开展Paxalisib单药及联合帕博利珠单抗的五臂II期临床试验
Kazia Therapeutics：Paxalisib单药治疗减轻肿瘤负担，联合Pembrolizumab进一步增效
美股速递 · 09-01 19:31
Kazia Therapeutics：Paxalisib单药治疗减轻肿瘤负担，联合Pembrolizumab进一步增效
Kazia Therapeutics扩展Paxalisib临床试验至HR+/HER2-乳腺癌，临床前数据显示其在HR+乳腺癌中具有强效活性与安全性
美股速递 · 09-01 19:15
Kazia Therapeutics扩展Paxalisib临床试验至HR+/HER2-乳腺癌，临床前数据显示其在HR+乳腺癌中具有强效活性与安全性
BioXcel Therapeutics：法院于2026年8月31日下达临时命令，预计2026年9月1日完成首笔950万美元提款及2975万美元债务滚动（SEC文件披露）
美股速递 · 09-01 19:09
BioXcel Therapeutics：法院于2026年8月31日下达临时命令，预计2026年9月1日完成首笔950万美元提款及2975万美元债务滚动（SEC文件披露）
BioXcel Therapeutics与橡树资本及卡塔尔投资局达成DIP信贷协议——SEC文件披露
美股速递 · 09-01 19:08
BioXcel Therapeutics与橡树资本及卡塔尔投资局达成DIP信贷协议——SEC文件披露
加载更多
公司概况
公司名称：
生物科技
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1361.6941,"timestamp":1788292799999,"preClose":1344.6246,"halted":0,"volume":646230723,"delay":0,"changeRate":0.012695,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":17.069458,"latestTime":"09-01 16:00:00 EDT","open":1344.6136,"high":1361.9126,"low":1344.6136,"amount":17550200949.932117,"amplitude":0.012865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.126907,"peRate":-107.782066,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"1158066419","title":"BioRestorative Therapies公司宣布任命Anna Skowron为首席财务官，自2026年8月27日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1158066419","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158066419?lang=zh_cn&edition=full","pubTime":"2026-09-02 18:06","pubTimestamp":1788343569,"startTime":"0","endTime":"0","summary":"BioRestorative Therapies, Inc.宣布，Anna Skowron将出任公司首席财务官一职，该任命自2026年8月27日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664989239","title":"美股中概股盘前多数下跌，蔚来跌3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664989239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664989239?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:01","pubTimestamp":1788336099,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0545039389.USD","09618","LU1235294995.USD","BBYY","LU0072462343.USD","BABX","LU0143863198.USD","09866","BK4122","LU1282648689.USD","BK4612","BK4510","LU0417516902.SGD","09626","688235","BK4614","BK4220","LU0106959298.USD","LU1023057109.AUD","ONC","HK0000306701.USD","LU0143863784.USD","LU1868838027.USD","LU0456842615.SGD","LU0708995583.HKD","LU2226246903.HKD","BABC","LI","LU0327786744.USD","LU0348825331.USD","LU1115378108.SGD","BK4099","LU1152091168.USD","BK4563","BK4548","IE0008368742.USD","LU0106252389.USD","LU0828237510.HKD","LU1688375341.USD","KBAB","LU1823568750.SGD","BK4585","HK0000320223.HKD","BK4575","LU1242518857.USD","LU0650527681.SGD","LU0949170772.SGD","LU0067412154.USD","LU0797268264.HKD","IE00BFMHRM44.USD","LU0048575426.USD","LU2148611432.USD","LU0128525689.USD","LU1868837722.USD","BK4139","BK4543","IE00BGV7N243.SGD","LU0310800965.SGD","LU0501845795.SGD","BK4551","LU0052756011.USD","BK4531","TCOM","LU2152927971.USD","JD","BK4535","BK4502","LU0326950275.SGD","LU0049853897.USD","LU1769817096.USD","BK4503","BK4533","IE00BPRC5H50.USD","LU1003077747.HKD","BK4574","LU0244354667.USD","LU1152091754.HKD","BK4558","LU1769817179.HKD","BABU","LU0979878070.USD","IE00B3M56506.USD","LU0210526637.USD","BK4554","LU0047713382.USD","09888","BK4505","BIDU","LU1048588211.SGD","BK4513","LU0329678337.USD","IE00BF5LJ272.USD","LU0251143458.SGD","LU0287142896.SGD","BABW","BK4565","LU0651947912.USD","LU0594300419.USD","BK4077","BK4526","LU0572944931.SGD","LU1242518931.SGD","LU0456827905.SGD","LU0661504455.SGD","LU0359201612.USD","BK4532","LU0315179316.USD","BK4142","NIO","LU1868837565.USD","BK4587","LU1961090484.USD","LU1048596156.SGD","ONLN","BK4534","LU0072913022.USD","LU1880383366.USD","BK4524","LU0307460666.USD","SG9999002463.SGD","BK4552","LU2399975544.HKD","BABO","BK4555","LU0348827113.USD","LU0880133367.SGD","LU1008478684.HKD","BK4577","LU0329678170.USD","BK4579","LU0738911758.USD","LU0348814723.USD","06160","BK4085","BK4504","09988","LU0348816934.USD","09961","BK4566","NIOG","02015","LU0320764599.SGD","LU0640798160.USD","LU0052750758.USD","LU0463099449.HKD","IE00B0JY6N72.USD","KBDU","ALBmain","NIO.SI","DRGN","LU1188198961.HKD","LU0359202008.SGD","BIDG","BILI","LU1046422090.SGD","LU0328353924.USD","EVS.SI","LU0048580855.USD","LU0039217434.USD","LU0370786039.SGD","LU0651946864.USD","LU0561508036.HKD","HK0000306685.HKD","BK4538","DRAG","KJD","LU0228659784.USD","LU1046421795.USD","LU0918141705.HKD","BK4602","LU1267930227.SGD","LU1720050803.USD","BK4607","LU0737861772.HKD","LU1051769294.HKD","IE00B543WZ88.USD","LU1794554557.SGD","LU0593848301.USD","LU0588546209.SGD","LU0553294199.USD","BK4527","BK4588","HK0000320264.USD","SG9999000475.SGD","LU1515016050.SGD","LU0051755006.USD","LU1105468828.SGD","LU0359201885.HKD","LU1051768304.USD","LU0173614495.USD","LU0261950470.USD","BK4514","LU0821914370.USD","BABA","BK4581","IE00B5MMRT66.SGD","CLIX","LU0918141887.USD","BK4509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898546","title":"再鼎医药早盘涨逾6% DLL3 ADC启动一线SCLC全球三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898546","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664898546?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:16","pubTimestamp":1788315360,"startTime":"0","endTime":"0","summary":"模拟交易客户端再鼎医药早盘涨逾6%。截至发稿，股价上涨5.97%，现报20.60港元，成交额5967.91万港元。8月31日，再鼎医药在Clinicaltrials.gov网站上注册了ZL-1310+PD-L1抗体一线治疗ES-SCLC的全球三期临床试验。该全球三期临床拟入组530例一线ES-SCLC患者，预计2030年6月初步完成。2026 年下半年重要催化剂包括：Zoci一线小细胞肺癌联合治疗数据公布、1L SCLC 及肺外神经内分泌癌注册性开发推进；ZL-1503首次人体数据公布等。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-02/doc-iniqkzme7832199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4531","BK1588","09688","BK1161","BK1574","BK4139","ZLAB","BK4526","BK4585","LU2488822045.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182455743","title":"昨夜今晨｜美伊冲突升级，三大指数下跌；苹果换帅首日涨近3%，戴尔绩后大涨，谷歌本周拟发Gemini 3.8 Flash","url":"https://stock-news.laohu8.com/highlight/detail?id=1182455743","media":"老虎资讯综合","labels":["AIColumn"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182455743?lang=zh_cn&edition=full","pubTime":"2026-09-02 07:03","pubTimestamp":1788303808,"startTime":"0","endTime":"0","summary":"长端美债收益率维持4.80%高位，令科技成长股承压，市场对9月通常偏弱的季节性表现保持谨慎。02 其他市场9月2日十年美债收益率上升0.00%，最新收益率为4.80%。9月2日美元指数上升0.0040%，报99.67。04 公司新闻苹果完成12年来首次管理层更迭，John Ternus正式出任CEO。Anthropic发布旗舰模型Fable 5.1，调用缓存费用下调75%。特斯拉公布欧版FSD监管数据，自主驾驶碰撞率较人工低4.1倍。Medtronic一季度盈利超预期并上调全年指引。","market":"uk","thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"AIColumn","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTYY","LU0784385840.USD","BK4612","TSLP","BK4077","LU1585245621.USD","USXF","LU1815336091.USD","MSTY.UK","SAVGOmain","IE0034235188.USD","LU1668664300.SGD","BK4020","LU2324357040.USD","LU0130517989.USD","IE0000B7K699.USD","RSPC","TSL","BK4559","AMZO","LU0130518102.USD","METW","IE00BD6J9T35.USD","BABA","IE00B2B36J28.USD","LU1804176565.USD","AAPE","LU1861220207.SGD","LU1989772923.USD","LU2430703178.SGD","IE00BN8TJ469.HKD","LU2756315664.SGD","IE00BZ9MQY76.HKD","LU0256863811.USD","LU2087625088.SGD","LU0312595415.SGD","07766","FBY","CHPX","VT","LU0106831901.USD","LU1983299246.USD","HULL","LU0244354667.USD","LU0820561909.HKD","LU2191332357.HKD","LU1551013342.USD","LU0889566641.SGD","LU0096362180.USD","IE00B7SZLL34.SGD","TSLA","IE0004086264.USD","SG9999001424.SGD","CLSE","LU0965509010.AUD","LU0211326839.USD","07711","XOMO","FDIG","LU0455707207.USD","GB00B4LPDJ14.GBP","LU0792757196.USD",".DJI","LU1670628061.USD","LU2097344357.USD","LU0348805143.USD","CGGO","FBX","GOOL","SKYY","LU1670710588.SGD","LU0823421333.USD","LU2322448957.HKD","LU2357305700.SGD","TESC","BK4567","LU0327786744.USD","IE00B19Z9Z06.USD","LU0633140727.USD","LU2720916845.USD","LU0823426480.USD","LU1430597077.USD","SOXQ","09788","LU0466842654.USD","LU1267930573.SGD","EFIV","LU2458330243.SGD","LU0965508806.USD","LU1961090484.USD","TINS","BK4142","LU1914381329.SGD","SMH","LU1868837300.USD","LU0417516902.SGD","LU1261432733.SGD","LU0823413587.USD","IE00B1BXHZ80.USD","LU0082616367.USD","LU1400636491.USD","LU0095938881.EUR","SMSN.UK","LU0918141887.USD","XOMZ","IE00BKPKM429.USD","LU0072462426.USD","NVDW","LU0820562030.AUD","LU0878005551.USD","LU1366192091.USD","MACW.SI","AVSE","LU2237957902.USD","LU0170899867.USD","SG9999002232.USD","LU0133085943.USD","LU0795875169.SGD","LU2362540622.SGD","LGHT","HAKY","LU0029864427.USD","LU1232071149.USD","LU0368265418.SGD","SG9999015952.SGD","IE00BFSS7M15.SGD","NOK","LU0130102774.USD","LU2097344431.USD","LU1242518931.SGD","NVC","LU1429558221.USD","TDIV","IE00B543WZ88.USD","LU0234570918.USD","LU2290526834.HKD","IE00B19Z8W00.USD","LU2210150020.SGD","LU1169589451.USD","09388","LU0879622024.SGD","LU0912757837.SGD","LU1718418525.SGD","AIFD","LU1152091754.HKD","LU0593848301.USD","LU0980610538.SGD","LU2168564149.EUR","LU0868486357.SGD","LU0516423091.SGD","LU2361045086.USD","LU1697837992.HKD","IE00BGV7N243.SGD","MSFW","LU2750360641.GBP","LU2413666699.HKD","LU0315179316.USD","LU2462157665.USD","LU0353189680.USD","LU1564329115.USD","SKUU","SKHN","IE00B4JS1V06.HKD","LU0566484027.USD","LU2236285917.USD","LU2237438978.USD","BK4504","ARTY","FINX","LU2552382058.USD","LU1645745479.HKD","IOSX","LU0726765562.USD","LU0965509101.SGD","LU1496350502.SGD","IE00BDGV0183.EUR","LU1150488218.USD","LU2750360997.AUD","VDE","LU2663582299.SGD","FBL","LU0384037296.USD","LU0979878070.USD","LU1934455863.HKD","LLII","LU2023250504.SGD","LU0456827905.SGD","LU1883839398.USD","SG9999014559.SGD","LU1989763005.USD","LU0198837287.USD","SKHL","ICOI","IE00BJTD4N35.SGD","CONY","BK5113","LU0719512351.SGD","LU2125154778.USD","LU1267930730.SGD","LU0390134368.USD","FIAT","LU1582986359.USD","LU1571399168.USD","LU0871640123.AUD","LU2275660780.HKD","LU0471298777.SGD","SG9999014898.SGD","LU0061474705.USD","LU1066051811.HKD","IE00B775H168.HKD","THNR","BILI","LU1732799900.SGD","LU0823411888.USD","CIR","FAI","LU0541501648.USD","LU0251143458.SGD","LU0069063385.USD","SG9999011175.SGD","LU2257852520.SGD","TSLZ","LU0557290698.USD","AVEM","BBYY","LU0130103400.USD","LU2129689605.HKD","IE00B2Q91V27.USD","LU2399975544.HKD","IE00BSNM7G36.USD","JDOC","BK4538","MRNX","WISE","CUL3","07709","SG9999015341.SGD","MEDX","LU3102509885.SGD","BK4543","LU0737861772.HKD","IE00BBT3K403.USD","LU1316542783.SGD","LU2065169927.USD","SK","3NVD.UK","LU0708995583.HKD","LU0347712357.USD","ASIA","KJD","SG9999015945.SGD","IE00B3SWFQ91.USD","LU0531971595.HKD","LU1105468828.SGD","GNOM","LU0098860793.USD","SG9999015978.USD","LU2098885051.SGD","LU1211504680.USD","LU0828237510.HKD","HK0000914686.HKD","FHLC","LU1929549753.HKD","HRTS","LU1778281490.HKD","LU2210149790.SGD","IXC","AMAA","LU1981816686.USD","LU0323591593.USD","LU0861579265.USD","LU1868837722.USD","LU2213496289.HKD","NVDS","MSTP","LU2247934214.USD","TEK","LU0889565833.HKD","LU1564329628.SGD","LU2102340556.USD","LU1923623000.USD","LU2764263039.SGD","MSTC","WEEI","LU1721428933.USD","GGLL","LU1548497426.USD","SKHA","LU1815336760.USD","SKHU","LU2125909593.SGD","LU2506951958.HKD","LU0823417737.USD","LU2637965513.SGD","LU2237443549.SGD","LLYZ","LU0203201768.USD","LU0820561818.USD","SNPE","LU2462611646.USD","LU0052756011.USD","IE00B7KXQ091.USD","BRK.A","IE000MB6IJN5.SGD","BK4085","LU0228659784.USD","LU0096364046.USD","LU0122376428.USD","IMST","LU0417517546.SGD","LU1868836591.USD","LU2471134952.CNY","METG","LU0821914370.USD","LU0742534661.SGD","CRCL","LU0266512473.USD","ONLN","CQTM","MSTY","PJP","LU0164865239.USD","LU2505996681.GBP","APLY","FDRV","LU0348825331.USD","GB00B4QBRK32.GBP","LU0053666078.USD","LU0965509283.SGD","LU0225283273.USD","LU1048588211.SGD","LU2417539215.USD","TSMY","LU0077335932.USD","LU2463028550.USD","SGXZ57979304.SGD","LU0266013472.USD","LU0359202008.SGD","IE00B5949003.HKD","AMZD","LU0187121727.USD","LU1989771016.USD","IE00B4YYXB79.USD","LU1127390331.HKD","LU0049853897.USD","LU1323610961.USD","LU1244550221.USD","LU1791710400.SGD","BK4570","LU0471298694.HKD","BK4505","LU1861127337.USD","METU","LU0348827113.USD","SG9999002562.SGD","SNVD.UK","LU2092937221.SGD","LU1769817179.HKD","III","LU0433182093.SGD","LU1057294990.SGD","VGT","MSTZ","LU1116320737.USD","LU2506951875.HKD","LU1979441026.SGD","BK4104","LU1670711123.USD","09866","IE00BF5LJ272.USD","LU1992135472.HKD","LU0051755006.USD","LU1121112475.USD","LU0545039389.USD","AGOX","PPH","IE00BDRTCR15.USD","LU1674673691.USD","IE00B3M56506.USD","LU2433249047.HKD","LU0049112450.USD","LU2237443978.SGD","TYLG","EVS.SI","IYE","2NVD.UK","IE00BVYPNP33.GBP","LU0320765489.SGD","LU1291159041.SGD","ESUM","LU0605514214.HKD","LU2168564495.EUR","LU2008162690.USD","LU2505996509.AUD","IE0031814852.USD","IE00BYXW3230.USD","AMZY","LU1992135399.USD","NVIW.SI","LU2095319765.USD","LU0957791311.USD","LU1221951046.USD","IE00B3S45H60.SGD","LU0528227936.USD","03145","IE00BVYPNQ40.USD","LU2129689514.USD","LU0162691827.USD","LU1037948897.HKD","SMOG","ELIS","LU1629891620.HKD","LU0823414551.USD","LU1960683339.HKD","09799","LU2226246903.HKD","IE00BDCRKT87.USD","QTWO","IE00BK4W5M84.HKD","LU0943347566.SGD","LU2087621335.USD","IE00B29SXG58.USD","LU1280957306.USD","LU2125909247.SGD","LU0985489474.SGD","LU1623119135.USD","LU1340139317.AUD","WATS","FBYY","IE00BQXX3F31.USD","XLK","LU0787776722.HKD","MSST","LU0211327993.USD","BK4579","LU0143863198.USD","LU2326559502.SGD","LU1983260115.SGD","SGXZ23171101.USD","VOX","NVDG","SKHX","LU0320765059.SGD","LU0210528500.USD","MSTW","FTEC","BK4513","DIG","LU1303224171.USD","AVL","FTXH","LU1064131342.USD","LU0067412154.USD","LU1008478684.HKD","AVGX","IE000KEQY171.SGD","LU0158827948.USD","IXJ","CONI","WLDR","AMZU","CGDG","KPDD","LU2237443382.USD","LU0894486033.HKD","LU1003077747.HKD","SGXZ81514606.USD","LU1880383440.USD","LU1188198961.HKD","OWNB","LU0985320562.USD","AMZN","LU1206712785.SGD","EMC","07347","LU1791710582.SGD","LU0048573561.USD","WANT","MSTU","BK4201","AMZG","LU0138981039.USD","LU0109392836.USD","IE00BGHQDM52.EUR","ELIL","BABU","LU0823397285.USD","SG9999001077.SGD","LU0612318971.USD","UDN","NVDL","BK4525","TRFK","IDNA","BK4134","IE00BMPRXQ63.HKD","LU0545562505.USD","07747","LU0276348264.USD","LU0784383803.USD","IE0003U64NQ7.SGD","LU0640476718.USD","LU2023250330.USD","BK4534","LU1956131251.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","IE00BFMHRM44.USD","IE0034235295.USD","09766","BK4176","LU0572940350.SGD","LU2237443622.USD","AAPL","BK4576","TLA","MSFC","BK4565","BK4168","LU2106854487.HKD","SG9999002224.SGD","LU0354030438.USD","MSII","SG9999014542.SGD","MSFD","LU2347655156.SGD","NIOG","LU0456846285.SGD","BK4502","LU1066051498.USD","GPRO","IE00BVYPNW00.USD","LU0444973449.USD","AAPW","FTXN","BK4588","WDNA","LU1769817096.USD",".IXIC","LU0300736062.USD","HK0000304797.USD","LU2362541273.HKD","LU0964807845.USD","LU2089284900.SGD","LU1282648689.USD","IBLC","HK0000914660.USD","LU0158827781.USD","LU0456855351.SGD","LU0957808578.USD","TEXU","BK4614","IE00BKVL7J92.USD","CIBR","BK4532","BABW","XLC","IE0004445015.USD","LU0289739343.SGD","DRLL","LU0496365809.HKD","LU1815333072.USD","HK0000306701.USD","BK4550","LU0316494557.USD","COIN","LU1883866441.USD","BK4558","LU1235294995.USD","LU0640798160.USD","LU0823417653.USD","JD","GOOX","LU1935043023.USD","IE00BJJMRX11.SGD","NVDS.UK","LU1496350171.SGD","LU1152091168.USD","LU0256863902.USD","IE000M9KFDE8.USD","LU1282649067.USD","LU2602419157.SGD","LU2077746001.SGD","LU2360106947.USD","BK4605","LU0859254822.USD","IE00BPRC5H50.USD","LU1852331112.SGD","IE00BLSP4452.SGD","CANC","LU0265550946.USD","AVGG","AMZP","MSFX","TSMZ","LU1770034418.SGD","LU1032955483.USD","HERO","IE000YTNTUN2.SGD","LU1116320901.HKD","LU0882574139.USD","AAPB","MSFO","LU0359201885.HKD","LU0320765646.SGD","LU1894683348.USD","GOOY","MEDI","CMAG","LU1923622614.USD","IE0005OL40V9.USD","ILDR","SG9999004220.SGD","LU0323239441.USD","LU0114720955.EUR","IE00BK4W5L77.USD","LU0477156797.USD","BK4608","LU2456880835.USD","IE00B42XCP33.USD","LU2100268510.USD","IE00B19Z8X17.USD","DB","LU1934455194.USD","MSTR","LU0056508442.USD","IE0008368742.USD","LU2089283258.USD","IE00BJJMRY28.SGD","LU0689472784.USD","TSM","LU0589944569.HKD","SG9999000418.SGD","LU1153585028.USD","BABC","IE0034390439.USD","BK4139","CONX","LU2054465674.USD","LU0097036916.USD","LU0320765992.SGD","LU0880133367.SGD","LU0329678170.USD","LU1059921491.USD","LU0203347892.USD","BK4572","BK4539","IXN","LU0265550359.USD","RXL","LU2413666426.HKD","XLE","SG9999014674.SGD","LU1642822529.SGD","EMM","BK4099","LU0878004406.USD","BK4141","LU1559883803.SGD","LU0211331839.USD","LU0689626769.HKD","LU0345780950.USD","BK4598","TSLI","BK4524","09399","LU1035773651.USD","LU1821325948.USD","IE00BN29S564.USD","LU2249611893.SGD","SG9999013999.USD","LU1489326972.SGD","BK4604","LU0784385170.HKD","OILT","LU0314104364.USD","CRCA","SG9999017495.SGD","LU0061474960.USD","SKHYV","LU1119994496.HKD","XOM","NVDX","GOOG","LU2394011477.USD","SAAPLmain","LFGY","LU2242644610.SGD","LU0106261372.USD","LU1228905540.USD","LU0651946864.USD","LU0552385451.USD","LU2168564222.USD","ANV","SKHZ","DRAG","LU2931357623.SGD","AMZZ","CLIX","LU0052750758.USD","LU0477156953.USD","LU2764262908.HKD","LU0476273544.USD","AIPI","BK4549","HK0000306685.HKD","CHAT","LU1974910355.USD","LU0106252389.USD","LU2462591277.SGD","LU1115378108.SGD","LU1868836914.USD","LU1674673428.USD","TSLQ","LU0251132253.USD","LU1093756168.USD","LU1861220033.SGD","LU1880398554.USD","LU1861217088.USD","LU0672654240.SGD","LU0264606111.USD","LU0107464264.USD","DAPP","IE00B5TLWC47.USD","LU0426412945.USD","BK4122","LU2468319806.SGD","IE00B19Z3581.USD","07366","ICRC","IE00BWXC8680.SGD","BK4552","LU2552382215.SGD","IE00B4R5TH58.HKD","LU1989764748.USD","BLOX","LU1202635105.USD","HYNX","NVII","LU0127658192.USD","LU2317271919.USD","BK4573","GDOC","SG9999001176.SGD","LU1699723380.USD","LU0432979614.USD","LU0630314457.HKD","USD","LU1169590202.USD","LU2065170008.USD","COIW","LU0006306889.USD","NVD3.UK","LU2242649171.HKD",".SPX","LU0310800965.SGD","BK4551","LU2125909916.SGD","IE0009356076.USD","LU0058720904.USD","RTH","BK4574","LU0724617625.USD","LU2063271972.USD","IE00BMPRXN33.USD","LU2404859741.USD","LU1670756490.USD","LU2087589342.USD","LU1206713676.USD","LU0238689110.USD","LU2362541513.USD","07388","SG9999002828.SGD","LU0976567544.SGD","LU0122379950.USD","LU0502904849.HKD","LU0516422952.EUR","LU2764263203.CNY","IE0009355771.USD","IE00BVYPNV92.GBP","LU0106959298.USD","LU1366333091.USD","LU1868837136.USD","LU0348788117.USD","IE00B3CCJ963.GBP","LU0654597011.USD","LU0308772762.SGD","LU0648001328.SGD","BK4581","SG9999015358.SGD","LU1935042488.USD","TSYY","SKHY","ODDS","LU2211815571.USD","USJW.SI","CCUP","LU2047632596.USD","JGRO","FCOM","LU1935042215.USD","LU0708994859.HKD","MSFL","LU2491049909.HKD","GXPC","STSLAmain","LU2111349929.HKD","TEST","COIA","IE00B775SV38.USD","ELOL","BK4577","LU1023057109.AUD","FXL","LU1035775433.USD","LU0287142896.SGD","LU1196500208.SGD","ESLG","LU1235295612.USD","LU0140636845.USD","MRNA","LU0143551892.USD","LU0708995401.HKD","IE00BJLML261.HKD","SG9999004303.SGD","LU0757359954.USD","SG9999014575.USD","LU2746668461.USD","SSNLF","LU2129689431.USD","AAPD","SOXX","IE00BMCWC346.EUR","LU2498475776.HKD","IE00B1XK9C88.USD","LU0011850046.USD","LU2133065610.SGD","LU0128525929.USD","LU0456842615.SGD","LU0345769631.USD","TSLW","LU0823434583.USD","LU1719994722.HKD","AIQ","LU0154236417.USD","BABO","LU0650527681.SGD","LU2279689827.SGD","IE00BQXX3D17.EUR","LU1582987324.SGD","BK4511","METD","LU0329678337.USD","SMETAmain","LU1868837565.USD","LU2322448791.USD","LU1688375341.USD","NVD","ERX","APED","LU0234572021.USD","LU0868494617.USD","IGV","BK4112","LU0328353924.USD","LU1235295455.SGD","TSII","HK0000819398.USD","IE00BQXX3C00.GBP","LU2896262040.SGD","DELL","BIDG","MST","LU0788109477.HKD","LU2491050154.USD","LU1046422090.SGD","NVDA","COIG","IE00BFXG0V08.USD","LU0274383776.USD","LU0289960550.SGD","IE00B19Z9505.USD","LU0472753341.HKD","LU0157215616.USD","IE0001KFT4U8.USD","LU1074936037.SGD","LIT","LU2592432038.USD","BK4607","LU0788109394.HKD","IE00BYQQ9H92.USD","BK4575","SGXZ31699556.SGD","LU0871576103.HKD","IETC","FDTX","LU1303367103.USD","CGBL","LU0786609619.USD","07399","AMZW","IE0009G5SDU7.USD","IE00BGHQF631.EUR","SG9999003800.SGD","LU2355687059.USD","LU2430703251.USD","BK4600","LU2360107168.USD","LU0310800379.SGD","LU2272731600.USD","LU1032466523.USD","GXPE","LU0651947912.USD","LU2999663052.SGD","LU0949170772.SGD","TSMG","LU1334329650.SGD","LU2152927971.USD","LU2458330169.SGD","BK4118","LU1803068979.SGD","LU1791807156.HKD","LU1691799644.USD","LU0251142724.SGD","IE00B0JY6N72.USD","SPWO","LNOK","LU2746668974.SGD","LU0259732245.USD","TSLS","LU0882747503.HKD","LU2177674079.SGD","LU1515016050.SGD","GOOP","CRSH","BK4097","BK4533","LU0149725797.USD","LU0203202063.USD","LU2491050071.SGD","SG9999014906.USD","CVX","LU0541502299.USD","LU2272731865.HKD","LU2298321311.HKD","LU0823426308.USD","LU0823038988.USD","HK0000165453.HKD","LU1582986433.USD","LU1720051017.SGD","LU0072461881.USD","NVYY","LU0370786039.SGD","MRNY","LU2360106780.USD","LU2462591350.SGD","LU1839511570.USD","LU2065171311.SGD","NIO","KBAB","LU0323240290.USD","LU0310799852.SGD","LU0516422366.SGD","LU0345770993.USD","LU0795875086.SGD","BK4512","BK4211","LU0823039010.USD","LU2272731782.SGD","LU0039217434.USD","LU0307460666.USD","LU1244550494.USD","MSFU","SG9999002463.SGD","SG9999015986.USD","IE00B894F039.SGD","BK4220","MSTX","NVDU","LU1670710661.SGD","LU1267930490.SGD","SG9999018865.SGD","LU1988902786.USD","BK4170","LU0081259029.USD","07311","LU2089985449.USD","CGNG","LU1282649810.SGD","LU0048584097.USD","MSOO","TSLT","LU0494093205.USD","BK4571","TRUC","BK4591","LU0047713382.USD","LMI3.UK","GAMR","LU1181866309.USD","ADVE","SNVDAmain","LU1150488135.SGD","LU0878866978.SGD","LU0359201612.USD","LU0594300419.USD","SG9999002521.SGD","LU0690374615.EUR","LU2487616109.SGD","LU0173614495.USD","LU0950375773.USD","SMSFTmain","LU0511384066.AUD","ESPO","IE0034235303.USD","LU2357125470.USD","09711","LU1188199696.SGD","LLY","LU1951198990.SGD","BAI","BK4515","BK4553","IE00B19Z3B42.SGD","LU0345781412.USD","DLLL","LU1236620750.USD","HK0000320264.USD","NTES","LU0516423174.USD","3SMI.UK","LU1670627923.USD","LU0395794307.EUR","LU2125909759.SGD","LU1228905037.USD","IE000Q6AESB8.SGD","LU0683600562.USD","LU0320764599.SGD","COII","LU0612318385.USD","LU0894485498.HKD","LU0757359368.USD","LU0348723411.USD","SGXZ80539844.SGD","LU2168563687.JPY","IE000SO60NU8.SGD","KBDU","LU2430703095.HKD","LU1880398471.USD","GB00BDT5M118.USD","LU0345774631.USD","TSMX","IE00BJT1NW94.SGD","LU1046421795.USD","LU2552382132.HKD","TSMU","FENY","LU2237443895.HKD","HK0000532082.HKD","LU1267930227.SGD","LU2404859667.USD","LU2361044949.HKD","LU0300736492.USD","SHOC","LU2471134523.USD","LU2250418816.HKD","LU2420271590.USD","LU2543165471.USD","LU0006061336.USD","LU1093756325.SGD","LU0175139822.USD","AVS","BK4509","LU2242650005.HKD","LU2065171402.SGD","BK4547","GOOGL","LU2271345857.HKD","GOU","IE0002270589.USD","LU1043141123.HKD","LU0488056044.USD","LU2452424414.USD","IHE","LU0994945656.USD","LU1951200564.SGD","07799","LU2092937148.SGD","LU0823434740.USD","BABX","LU2092627202.USD","BK4602","LU0757428866.USD","META","LU1066051225.USD","IE00BLSP4239.USD","LU1435385759.SGD","CGIC","LU2211814178.USD","LU0348814723.USD","IE00BGHQF524.EUR","LU0353189763.USD","BK4501","KWEB","LU2237957811.SGD","LU0648000940.SGD","IE00BFXG1179.USD","SG9999014914.USD","LU1989764664.SGD","LU2148611432.USD","MSTR.AU","3LMI.UK","AAPY","LU0211326755.USD","LU0348816934.USD","TSLL","LU1400636657.SGD","LU0070302665.USD","LU0345768740.USD","LU1236620834.HKD","LU0231483743.USD","LU0203345920.USD","BK4535","LU0431992006.USD","BK4516","LU2471134796.USD","LU2108987350.USD","TCOM","TMED","BK4585","BLCK","IE0002141913.USD","LU0784384876.USD","LU2506951792.HKD","BK4514","MEMX","BK4531","LU0210526637.USD","IE00BZ1G4Q59.USD","TTXU","AVGW","NVDQ","LU1923622291.USD","IE000ITXATA3.USD","SG9999001176.USD","SG9999000475.SGD","IE00B19Z9P08.USD","LU1051769294.HKD","BK4599","LU1989772840.SGD","LU0143863784.USD","LU0211328371.USD","LU2471134879.HKD","LU1201861249.SGD","IE00BFSS8Q28.SGD","LU0633140560.USD","SG9999018857.SGD","NVDB","BK4566","TRUH","GGLS","MSFT","NVDO","LU0385154629.USD","LU1880383366.USD","LU0068578508.USD","IE000W1ABFV2.USD","IE000F7OJYX1.SGD","IE000WAW04H5.SGD","LU1043141396.HKD","LU0354030511.USD","NVDY","LU1400636574.HKD","SG9999001440.SGD","LU2265009873.SGD","PDD","LU0094547139.USD","STSM","LU0516422440.USD","LU0117841782.USD","CURE","LU0882574055.USD","LU0266512127.USD","LU2023251221.USD","LU1171460220.USD","LU2286300806.USD","SGXZ51526630.SGD","BK4555","LU0235996351.USD","ROM","BK4561","LU0553294199.USD","VHT","IE00BHPRN162.USD","CONL","LU0868494708.USD","LU1935043536.SGD","LU0278409577.USD","LU0823416689.USD","IE00BZ199S13.USD","LU0215105999.USD","NVDD","LU0683595622.HKD","HK0000320223.HKD","LU2264538146.SGD","BK4078","LU1145028129.USD","LU1794554557.SGD","LU0661504455.SGD","SG9999014567.USD","LU1720051108.HKD","LU0342679015.USD","LU0960925559.SGD","METV","LU0057025933.USD","BK4568","09311","UUP","LU1037948541.HKD","IE0004445239.USD","NVD2.UK","LU2461242641.AUD","LU2506952170.USD","LU0561508036.HKD","IE00BKDWB100.SGD","LU0171293334.USD","AGNG","LU2347655073.USD","WNTR","SOCL","LU0210533765.USD","LU0070217475.USD","XLV","BK4554","LU2860962120.EUR","LU1430594728.SGD","IE0004091025.USD","LU2112291526.USD","ESIM","LU1048596156.SGD","LU0823414478.USD","IE00B5MMRT66.SGD","IE000BZT7R73.USD","COPP","LU0124676726.USD","CNEQ","LU2954938101.SGD","NERD","LU1861215975.USD","LU2244417387.USD","AVGO","SMI3.UK","THMR","LU1720050803.USD","LU1582987597.SGD","LU0128525689.USD","LU0314106906.USD","BK4510","LU1732800096.USD","LU1917777945.USD","GOGL","AVGC","IE0034224299.USD","LU2089984988.USD","LU1808992512.USD","SAMZNmain","LU0463099449.HKD","BK4526","IE00BJTD4V19.USD","LU2028103732.USD","LU0256331488.USD","LU0251131958.USD","LU0738911758.USD","SMST","LU1934455277.USD","TSLG","ABFL","NULC","LU2360108059.USD","09366","LU0345770308.USD","IE00BYV24P56.USD","LU2756315318.SGD","IYH","AAPX","SGOOGmain","LU2506952097.USD","CWI","LU1670711040.USD","LU0501845795.SGD","LU1051768304.USD","LU0594300179.USD","LU0072462343.USD","SG9999014880.SGD","SMHX","BK4587","LTL","IE00BMPRXR70.SGD","HBM","LU1993786604.SGD","XOMX","LU1861558580.USD","CRPT","LU2083900584.USD","LU1935042991.SGD","LU1244550577.SGD","LU0289961442.SGD","LU1564329032.USD","07788","LU1144417596.USD","LU0588546209.SGD","LU1807302812.USD","SOXY","HK0000304805.HKD","LU2125154935.USD","LU0426417589.USD","BKCH","LU0690374961.EUR","BK4023","LU1084165304.USD","ALBmain","OZEM","LU0048580855.USD","LU0109391861.USD","LU1551013425.SGD","CRCO","LU2473716301.USD","LU1201861165.SGD","BK4507","MHIP","LU0949170426.SGD","BK4548","09988","LU1221951129.SGD","TSDD","LU1508157978.USD","BK4503","LU0572939691.SGD","LU0079474960.USD","LU0823397103.USD","LU2039709279.SGD","LU1803068623.USD","MSFY","LU1301847155.USD","LU1868836757.USD","TTEQ","SGXZ44715902.SGD","BITQ","LU2168564065.EUR","TRUN","LU0889565916.HKD","LU1066053197.SGD","LU2279858448.HKD","IDRV","LU2381873111.SGD","LU2360032135.SGD","COIX","LU1868838027.USD","MSTK","SPTE","TESL","AVXC","LU1861559042.SGD","LU1242518857.USD","TSLR","LU0345768153.USD","BK4595","LU0289739699.SGD","09618","IE00B3PB1722.GBP","LU1251922891.USD","XDAT","LU2294711713.HKD","LU0267386448.USD","FDNI","LU0942090050.USD","LU0326950275.SGD","CRCG","NIO.SI","LU1564329461.SGD","PDDL","LU0174119429.USD","LU2360107671.USD","MSDD","LU2237443465.HKD","LU2041044095.USD","LU0289941410.SGD","BK4596","CORO","LU0642271901.SGD","LU0210536198.USD","LU0444971666.USD","IGE","LU0048575426.USD","LU0080751232.USD","UMMA","LU2211817866.USD","GOOW","LU0261950470.USD","LU0918141705.HKD","DIPS","LU1712237335.SGD","LU2097829019.USD","LU1894683264.USD","AZYY","LU0572944931.SGD","LU1506573853.SGD","DRGN","LU0208291251.USD","LLYX","LU0797268264.HKD","LU1989773731.SGD","BK4527","OGIG","AAPU","TSLO","LU2357627491.SGD","LU0823413660.USD","AVGU","TWSC","LU1814569148.SGD","LU0823421416.USD","SKDD","LU2023250843.SGD","LU1823568750.SGD","IE00BJJMRZ35.SGD","KNOW","METQ","LU0345769128.USD","CRCD","TSLY","FISI","BK4563","LU1633808545.USD","SGXZ99366536.SGD","LU0345774391.USD","BK4529","BK4007","LU1069344957.HKD",".HXC","LU1061106388.HKD","LU1162221912.USD","COIO","IE00B19Z6F94.USD","LU0456854461.SGD","LU0061475181.USD","BK4592","AL","BK4528","LU2361044865.SGD","LU1069347547.HKD","LU0109394709.USD","COYY","WUGI","USAW.SI","LI","LU2403377893.USD","LU0302445910.USD","LU1323998911.USD","LU0072913022.USD","LU1023059063.AUD","BIDU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861043","title":"美国财长贝森特谈及债券收益率：最重要的是实现更高水平的经济增长。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664861043?lang=zh_cn&edition=full","pubTime":"2026-09-02 06:14","pubTimestamp":1788300846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RJVI","MOOD","MYHC","DRVR","IBDK","INSI","IGCB","THY","HIMU","BK4139","FSLD","HDLB","MDPL","DRKY","FDIV","CCSB","JHCB","FLXN","SYSB","IBDY","HYBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114654796","title":"Hyperliquid Strategies于2026年9月1日签署主厨购买协议第一修正案——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1114654796","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114654796?lang=zh_cn&edition=full","pubTime":"2026-09-02 05:02","pubTimestamp":1788296537,"startTime":"0","endTime":"0","summary":"Hyperliquid Strategies——于2026年9月1日就主厨购买协议正式订立第一修正案——此项变动已通过美国证券交易委员会（SEC）文件对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PURR","PUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139567683","title":"aTyr Pharma更新计划中Efzofitimod治疗肺结节病III期研究的监管反馈时间表","url":"https://stock-news.laohu8.com/highlight/detail?id=1139567683","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139567683?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:37","pubTimestamp":1788295071,"startTime":"0","endTime":"0","summary":"aTyr Pharma日前就其在研药物Efzofitimod（用于治疗肺结节病）所计划的III期临床研究的监管反馈时间，对外发布了最新动态。此次更新为公司的研发进程提供了新的时间参考框架，并明确了接下来与监管机构沟通的关键节点。公司方面表示，目前正就该项研究的方案设计与相关监管当局保持沟通，并期待在既定时间表内获得进一步指引。该更新公告旨在向投资者及业界同步最新进展，以体现公司在推进这一潜在治疗方案上的持续努力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149776488","title":"Emergent BioSolutions获增购Cyfendus（Av7909）合同修订——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149776488","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149776488?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:15","pubTimestamp":1788293710,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions（纽交所代码：EBS）于近日向美国证券交易委员会（SEC）提交了一份文件，披露其合同修订情况。\n该修订涉及该公司旗下炭疽疫苗产品Cyfendus（Av7909）的额外采购。根据修订条款，采购方将在原有基础上追加订购更多剂量的Cyfendus。\n这笔增购交易的具体金额和交付时间表尚未在文件中详细披露。公司方面表示，此次合同修改反映了采购方对该疫苗产品的持续需求。\n文件提交后，市场对此消息暂无重大反应。Emergent BioSolutions是一家专注于公共卫生防护领域的生物制药公司，其产品线涵盖炭疽、天花等生物威胁相关疫苗及治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192232987","title":"Ultragenyx宣布Genglycos™（亦称DTX401）AAV基因疗法治疗GSD Ia的96周随机安慰剂对照交叉试验成功发表于《遗传代谢病杂志》","url":"https://stock-news.laohu8.com/highlight/detail?id=1192232987","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192232987?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:07","pubTimestamp":1788293247,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical今日宣布，其针对Ia型糖原贮积病的AAV基因疗法Genglycos所开展的一项长达96周的随机、安慰剂对照、交叉设计临床试验，其研究成果已正式发表于权威期刊《遗传代谢病杂志》。该项研究历时近两年，采用严谨的双盲、随机、安慰剂对照方法，并在后期阶段引入交叉治疗设计，旨在全面评估Genglycos在GSD Ia患者群体中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181679733","title":"阿尔法计算公司获纳斯达克额外180天宽限期，以满足最低股价要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1181679733","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181679733?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:07","pubTimestamp":1788282470,"startTime":"0","endTime":"0","summary":"阿尔法计算公司（Alpha Compute Corp.）宣布，已获得纳斯达克授予的额外180天宽限期，以重新满足其最低出价要求。这一关键的缓冲时间，为公司争取到了扭转局面的宝贵机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140980227","title":"FibroBiologics宣布获得美国新专利：利用成纤维细胞条件培养基治疗椎间盘退行性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1140980227","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140980227?lang=zh_cn&edition=full","pubTime":"2026-09-01 20:31","pubTimestamp":1788265870,"startTime":"0","endTime":"0","summary":"FibroBiologics今日宣告，其一项针对椎间盘退行性疾病治疗的新美国专利已正式获批。此项专利聚焦于成纤维细胞条件培养基的应用，为该疾病的治疗开辟了全新路径。这标志着公司在再生医学领域的持续深耕又迈出了坚实一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152230727","title":"Valion Bio Inc宣布高层任命：Lisa Wolf出任总裁兼首席运营官，并继续兼任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1152230727","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152230727?lang=zh_cn&edition=full","pubTime":"2026-09-01 20:12","pubTimestamp":1788264748,"startTime":"0","endTime":"0","summary":"Valion Bio Inc（VBIO）今日发布重要人事任命公告。据悉，Lisa Wolf已正式被委任为公司总裁兼首席运营官（President & Chief Operating Officer）。值得注意的是，在履新上述职务的同时，她还将继续肩负首席财务官（CFO）的重任。此番人事调整，标志着公司管理层架构迎来关键性变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187632223","title":"KALA BIO携手Virotek，拟签署美国独家经销协议，共同推进眼科基因检测项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1187632223","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187632223?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:45","pubTimestamp":1788263114,"startTime":"0","endTime":"0","summary":"KALA BIO与Virotek联合宣布，双方已达成意向书，计划建立一项针对眼科基因检测项目的美国独家经销合作伙伴关系。这一举措标志着两家公司在精准医疗领域的深度布局迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","KALA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145784120","title":"Kazia Therapeutics公布临床前数据：Paxalisib可重编程免疫治疗耐药的MSS/pMMR结直肠癌并增强免疫治疗应答","url":"https://stock-news.laohu8.com/highlight/detail?id=1145784120","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145784120?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:31","pubTimestamp":1788262289,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics于今日披露了关键的临床前研究结果。数据显示，其在研药物Paxalisib能够对免疫治疗耐药的微卫星稳定型/错配修复功能完整型结直肠癌进行重编程，从而显著提升免疫治疗的疗效。众所周知，MSS/pMMR类型的结直肠癌对现有免疫疗法反应欠佳，一直是肿瘤治疗领域的难点。Kazia Therapeutics强调，这些数据为后续临床开发奠定了坚实基础。公司正积极评估Paxalisib在结直肠癌及其他实体瘤中的应用潜力，以期解决这一高度未满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138979725","title":"Kazia Therapeutics二期试验预计2027年第一季度启动入组，年底前完成全部招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1138979725","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138979725?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:31","pubTimestamp":1788262288,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics（KZIA）宣布，其二期试验的患者入组工作预计将于2027年第一季度正式启动，并计划在2027年底前实现全部入组目标。这一时间表标志着该临床项目进入关键推进阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181542089","title":"Kazia Therapeutics计划开展Paxalisib单药及联合帕博利珠单抗的五臂II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1181542089","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181542089?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:31","pubTimestamp":1788262282,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited宣布，其正筹划一项涵盖五个治疗组的II期临床试验，旨在评估Paxalisib作为单药疗法以及与帕博利珠单抗联合使用的疗效。该试验设计体现了公司对多维度探索治疗潜力的战略布局。值得注意的是，五臂设计不仅囊括了单药治疗组，还设置了多种联合给药方案，以全面比较不同治疗策略下的临床获益。这一举措或将为相关适应症的治疗格局带来新的启示，也标志着Kazia在肿瘤精准医疗领域的又一关键推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165043700","title":"Kazia Therapeutics：Paxalisib单药治疗减轻肿瘤负担，联合Pembrolizumab进一步增效","url":"https://stock-news.laohu8.com/highlight/detail?id=1165043700","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165043700?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:31","pubTimestamp":1788262277,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics公布最新研究进展——Paxalisib作为单药疗法，成功降低了肿瘤负担。更令人瞩目的是，当加入Pembrolizumab后，疗效得到进一步显著提升，肿瘤负担呈现更大幅度的缩减。这一发现为联合治疗策略提供了有力证据，或有望为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190879896","title":"Kazia Therapeutics扩展Paxalisib临床试验至HR+/HER2-乳腺癌，临床前数据显示其在HR+乳腺癌中具有强效活性与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1190879896","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190879896?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics宣布，将Paxalisib的临床试验范围扩展至HR+/HER2-乳腺癌领域。这一决策背后，有坚实的临床前数据作为支撑——这些数据清晰地展示了Paxalisib在HR+乳腺癌中的显著临床活性与良好的安全特性。Paxalisib作为一种在研药物，其潜力正在被逐步挖掘。Kazia Therapeutics此次行动，标志着其在肿瘤治疗领域的又一重要布局。整体来看，这一战略举措反映了Kazia Therapeutics致力于推进创新疗法的决心。随着试验的深入，Paxalisib的临床应用前景或将更加明朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127368326","title":"BioXcel Therapeutics：法院于2026年8月31日下达临时命令，预计2026年9月1日完成首笔950万美元提款及2975万美元债务滚动（SEC文件披露）","url":"https://stock-news.laohu8.com/highlight/detail?id=1127368326","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127368326?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:09","pubTimestamp":1788260940,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics在最新提交给美国证券交易委员会（SEC）的文件中披露，一项临时命令已于2026年8月31日正式生效。根据该命令，公司预计将在2026年9月1日执行首笔950万美元的提款操作，同时推进一项总额达2975万美元的债务滚动安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104915211","title":"BioXcel Therapeutics与橡树资本及卡塔尔投资局达成DIP信贷协议——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1104915211","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104915211?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:08","pubTimestamp":1788260927,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics公司宣布，已与橡树资本及卡塔尔投资局正式签署了一项债务人持有资产信贷协议。该消息源自公司向美国证券交易委员会提交的最新文件。根据协议条款，BioXcel Therapeutics将获得来自这两家全球知名投资机构的资金支持，以维持其运营流动性和推进核心业务发展。从行业视角来看，DIP融资通常被视为企业应对财务挑战、寻求重整的重要工具。BioXcel Therapeutics此举能否有效缓解其资金压力并重新聚焦研发管线，市场将拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.01},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.181},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}